Tocilizumab Patterns of Use, Effectiveness, and Safety in Patients with Rheumatoid Arthritis: Final Results from a Set of Multi-National Non-Interventional Studies

被引：0
|
作者：
Boulos Haraoui
Gustavo Casado
László Czirják
Andrew Taylor
Lingli Dong
Peter Button
Yves Luder
Roberto Caporali
机构：
[1] Institut de Rhumatologie de Montréal,Department of Rheumatology
[2] Hospital Militar Central,Rheumatology and Immunology Clinic, Medical Center
[3] University of Pécs,Medicine and Pharmacology RPH Unit, Royal Perth Hospital
[4] University of Western Australia,Department of Rheumatology and Immunology, Tongji Hospital, Tongji Medical College
[5] Huazhong University of Science and Technology,Department of Rheumatology
[6] OzBiostat Pty Ltd,undefined
[7] F. Hoffmann-La Roche,undefined
[8] Ltd,undefined
[9] University of Pavia,undefined
[10] IRCCS S. Matteo Foundation,undefined
来源：
Rheumatology and Therapy | 2019年 / 6卷
关键词：
ACT-UP; Biologic factors; Rheumatoid arthritis; Tocilizumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：231 / 243
页数：12
相关论文
共 38 条
  • [21] Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
    Koike, Takao
    Harigai, Masayoshi
    Inokuma, Shigeko
    Ishiguro, Naoki
    Ryu, Junnosuke
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Yamanaka, Hisashi
    Fujii, Koichi
    Yoshinaga, Takunari
    Freundlich, Bruce
    Suzukawa, Michio
    RHEUMATOLOGY INTERNATIONAL, 2012, 32 (06) : 1617 - 1624
  • [22] Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
    Takao Koike
    Masayoshi Harigai
    Shigeko Inokuma
    Naoki Ishiguro
    Junnosuke Ryu
    Tsutomu Takeuchi
    Yoshiya Tanaka
    Hisashi Yamanaka
    Koichi Fujii
    Takunari Yoshinaga
    Bruce Freundlich
    Michio Suzukawa
    Rheumatology International, 2012, 32 : 1617 - 1624
  • [23] Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
    Eugen Feist
    Xenofon Baraliakos
    Frank Behrens
    Diamant Thaçi
    Thilo Klopsch
    Anja Plenske
    Lisa K. Blindzellner
    Pascal Klaus
    Thomas Meng
    Peter-Andreas Löschmann
    Rheumatology and Therapy, 2022, 9 : 621 - 635
  • [24] Long-term safety and effectiveness of adalimumab for the treatment of Japanese patients with rheumatoid arthritis: 3-year results from a postmarketing surveillance of 552 patients
    Harigai, Masayoshi
    Tsuchiya, Tsuyoshi
    Kawana, Katsuyoshi
    Kurimoto, Sarina
    MODERN RHEUMATOLOGY, 2018, 28 (01) : 30 - 38
  • [25] Effectiveness of Etanercept in Rheumatoid Arthritis: Real-World Data from the German Non-interventional Study ADEQUATE with Focus on Treat-to-Target and Patient-Reported Outcomes
    Feist, Eugen
    Baraliakos, Xenofon
    Behrens, Frank
    Thaci, Diamant
    Klopsch, Thilo
    Plenske, Anja
    Blindzellner, Lisa K.
    Klaus, Pascal
    Meng, Thomas
    Loeschmann, Peter-Andreas
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 621 - 635
  • [26] Results of a 12-Week Open-Label, Non-Interventional Study of the Efficacy and Safety of Olokizumab Therapy in Patients with Rheumatoid Arthritis after Switching from Anti-B-Cell Therapy during the SARS-CoV-2 Pandemic
    Akimova, A. A.
    Banshchikova, N. E.
    Sizikov, A. E.
    Mullagaliev, A. A.
    Letyagina, E. A.
    Ilina, N. A.
    Kurochkina, Y. D.
    Ubshaeva, Y. B.
    Omelchenko, V. O.
    Chumasova, O. A.
    Shkaruba, N. S.
    Korolev, M. A.
    DOKLADY BIOCHEMISTRY AND BIOPHYSICS, 2024, 518 (01) : 291 - 299
  • [27] Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Up to 3-year results from a postmarketing surveillance study
    Kameda, Hideto
    Nishida, Keiichiro
    Nanki, Toshihiro
    Watanabe, Akira
    Oshima, Yukiya
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2024, : 1103 - 1114
  • [28] Safety and effectiveness of certolizumab pegol in Japanese patients with rheumatoid arthritis: Results from a 24-week post-marketing surveillance study
    Kameda, Hideto
    Nishida, Keiichiro
    Nanki, Toshihiro
    Watanabe, Akira
    Oshima, Yukiya
    Momohara, Shigeki
    MODERN RHEUMATOLOGY, 2023, 33 (03) : 460 - 471
  • [29] Cigarette smoking and clinical response to certolizumab pegol treatment in Hungarian, Czech, and Slovak patients with rheumatoid arthritis: 104-week data from the CIMDORA prospective, non-interventional study
    Szekanecz, Z.
    Koncz, A.
    Dunkel, J.
    Vencovsky, J.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (06) : 1010 - 1018
  • [30] Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study
    Honda, Suguru
    Sakai, Ryoko
    Inoue, Eisuke
    Majima, Masako
    Konda, Naoko
    Takada, Hideto
    Kihara, Mari
    Yajima, Nobuyuki
    Nanki, Toshihiro
    Yamamoto, Kazuhiko
    Takeuchi, Tsutomu
    Harigai, Masayoshi
    MODERN RHEUMATOLOGY, 2022, 32 (01) : 16 - 23
1234